Management of Joint Contractures in the Spastic Upper Extremity.
Upper extremity contractures in the spastic patient may result from muscle spasticity, secondary muscle contracture, or joint contracture.
APA
Wood KS, Daluiski A (2018). Management of Joint Contractures in the Spastic Upper Extremity.. Hand clinics, 34(4), 517-528. https://doi.org/10.1016/j.hcl.2018.06.011
MLA
Wood KS, et al.. "Management of Joint Contractures in the Spastic Upper Extremity.." Hand clinics, vol. 34, no. 4, 2018, pp. 517-528.
PMID
30286966
Abstract
Upper extremity contractures in the spastic patient may result from muscle spasticity, secondary muscle contracture, or joint contracture. Knowledge of the underlying cause is critical in planning successful treatment. Initial management consists of physical therapy and splinting. Botulinum toxin can be helpful, as a therapeutic treatment in relieving spasticity and as a diagnostic tool in determining the underlying cause of the contracture. Surgical management options include release or lengthening of the causative muscle/tendon unit and joint capsular release, as required. Postoperative splinting is important to maintain the improved range of motion and protect any associated tendon lengthening or transfer.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 |
MeSH Terms
Arthrodesis; Cerebral Palsy; Contracture; Humans; Humerus; Joint Dislocations; Joints; Muscle Spasticity; Osteotomy; Physical Therapy Modalities; Postoperative Care; Splints; Tendons; Tenotomy; Upper Extremity
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.